Loading...
business
The Obesity Drug Loophole. Plus, the Outlook for Homebuilder Stocks.
About this Episode
Also, a top Vanguard strategist discusses the run-up in growth stocks.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Hosts & Guests
No transcript available for this episode.
